STOCK TITAN

[S-8] Cerus Corp Employee Benefit Plan Registration

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
S-8
Rhea-AI Filing Summary

Alphatec Holdings, Inc. (ATEC) – Form 144 Notice of Proposed Sale

Insider Tyson Marshall intends to sell up to 18,092 common shares via Morgan Stanley Smith Barney on or about 5 Aug 2025. At the filing price the lot is worth $269,688.68. With 147,983,775 shares outstanding, the sale represents roughly 0.012 % of ATEC’s float.

The shares stem from restricted-stock vesting under a registered compensation plan. Marshall has already sold 14,378 shares in the prior three months for $171,952, bringing recent and proposed disposals to 32,470 shares (≈ 0.022 % of shares outstanding).

The filer certifies no undisclosed adverse information and signs the standard Rule 144 representation. No other operational or financial data are provided.

Alphatec Holdings, Inc. (ATEC) – Avviso di Vendita Proposta ai sensi della Form 144

L'insider Tyson Marshall intende vendere fino a 18.092 azioni ordinarie tramite Morgan Stanley Smith Barney intorno al 5 agosto 2025. Al prezzo di deposito, il lotto ha un valore di 269.688,68 $. Con 147.983.775 azioni in circolazione, la vendita rappresenta circa lo 0,012 % del flottante di ATEC.

Le azioni derivano da un vesting di azioni vincolate nell'ambito di un piano di compensazione registrato. Marshall ha già venduto 14.378 azioni nei tre mesi precedenti per 171.952 $, portando il totale delle vendite recenti e proposte a 32.470 azioni (circa lo 0,022 % delle azioni in circolazione).

Il dichiarante certifica l'assenza di informazioni negative non divulgate e firma la dichiarazione standard prevista dalla Regola 144. Non sono forniti altri dati operativi o finanziari.

Alphatec Holdings, Inc. (ATEC) – Aviso de Venta Propuesta según el Formulario 144

El insider Tyson Marshall planea vender hasta 18,092 acciones comunes a través de Morgan Stanley Smith Barney alrededor del 5 de agosto de 2025. Al precio declarado, el lote tiene un valor de $269,688.68. Con 147,983,775 acciones en circulación, la venta representa aproximadamente el 0.012 % del float de ATEC.

Las acciones provienen de la consolidación de acciones restringidas bajo un plan de compensación registrado. Marshall ya ha vendido 14,378 acciones en los últimos tres meses por $171,952, sumando disposiciones recientes y propuestas a 32,470 acciones (≈ 0.022 % de las acciones en circulación).

El declarante certifica que no posee información adversa no divulgada y firma la representación estándar requerida por la Regla 144. No se proporcionan otros datos operativos o financieros.

Alphatec Holdings, Inc. (ATEC) – Form 144 제안된 매각 통지

내부자 Tyson Marshall는 2025년 8월 5일경 Morgan Stanley Smith Barney를 통해 최대 18,092 보통주를 매각할 예정입니다. 신고 가격 기준으로 해당 주식의 가치는 $269,688.68입니다. 총 147,983,775주가 발행된 가운데, 이번 매각은 ATEC 유통 주식의 약 0.012 %에 해당합니다.

이 주식은 등록된 보상 계획에 따른 제한 주식 권리 확정에서 비롯된 것입니다. Marshall은 지난 3개월 동안 이미 14,378주$171,952에 매각했으며, 최근 및 제안된 매각 총량은 32,470주(전체 주식의 약 0.022 %)에 이릅니다.

신고자는 공개되지 않은 부정적 정보가 없음을 증명하며, 표준 Rule 144 진술서에 서명했습니다. 다른 운영 또는 재무 데이터는 제공되지 않았습니다.

Alphatec Holdings, Inc. (ATEC) – Avis de vente proposée au titre du formulaire 144

L'initié Tyson Marshall prévoit de vendre jusqu'à 18 092 actions ordinaires via Morgan Stanley Smith Barney aux alentours du 5 août 2025. Au prix déclaré, le lot vaut 269 688,68 $. Avec 147 983 775 actions en circulation, la vente représente environ 0,012 % du flottant d'ATEC.

Les actions proviennent d'un acquisition d'actions restreintes dans le cadre d'un plan de rémunération enregistré. Marshall a déjà vendu 14 378 actions au cours des trois derniers mois pour 171 952 $, portant le total des cessions récentes et proposées à 32 470 actions (≈ 0,022 % des actions en circulation).

Le déclarant certifie qu'il n'y a pas d'informations défavorables non divulguées et signe la déclaration standard prévue par la règle 144. Aucune autre donnée opérationnelle ou financière n'est fournie.

Alphatec Holdings, Inc. (ATEC) – Form 144 Mitteilung über geplanten Verkauf

Insider Tyson Marshall beabsichtigt, bis zu 18.092 Stammaktien über Morgan Stanley Smith Barney etwa am 5. August 2025 zu verkaufen. Zum Einreichungspreis hat das Paket einen Wert von 269.688,68 $. Bei 147.983.775 ausstehenden Aktien entspricht der Verkauf etwa 0,012 % des frei handelbaren Bestands von ATEC.

Die Aktien stammen aus der Vesting von eingeschränkten Aktien im Rahmen eines registrierten Vergütungsplans. Marshall hat in den letzten drei Monaten bereits 14.378 Aktien für 171.952 $ verkauft, womit sich die jüngsten und geplanten Verkäufe auf 32.470 Aktien (ca. 0,022 % des ausstehenden Aktienkapitals) summieren.

Der Anmelder bestätigt, dass keine nicht offengelegten negativen Informationen vorliegen, und unterzeichnet die Standarderklärung gemäß Regel 144. Weitere operative oder finanzielle Daten werden nicht bereitgestellt.

Positive
  • Proposed sale is immaterial at roughly 0.012 % of outstanding shares, limiting potential market impact.
Negative
  • Continued insider selling (32,470 shares over three months) can be perceived negatively by some investors.

Insights

TL;DR: Small insider sale (<0.02 % of float); unlikely to pressure ATEC shares materially.

The Form 144 shows Tyson Marshall planning to dispose of 18,092 newly-vested restricted shares, valued at about $270 k. Even when combined with the 14,378 shares sold during the last quarter, the aggregate 32,470 shares equal only 0.022 % of Alphatec’s 148 m share base. Such volume is typically absorbed without meaningful price impact, suggesting a neutral signal for liquidity and valuation.

The filing offers no insight into company fundamentals; therefore, investors should treat this as routine insider diversification rather than a directional indicator. The absence of adverse-information disclaimers further supports a neutral reading.

Alphatec Holdings, Inc. (ATEC) – Avviso di Vendita Proposta ai sensi della Form 144

L'insider Tyson Marshall intende vendere fino a 18.092 azioni ordinarie tramite Morgan Stanley Smith Barney intorno al 5 agosto 2025. Al prezzo di deposito, il lotto ha un valore di 269.688,68 $. Con 147.983.775 azioni in circolazione, la vendita rappresenta circa lo 0,012 % del flottante di ATEC.

Le azioni derivano da un vesting di azioni vincolate nell'ambito di un piano di compensazione registrato. Marshall ha già venduto 14.378 azioni nei tre mesi precedenti per 171.952 $, portando il totale delle vendite recenti e proposte a 32.470 azioni (circa lo 0,022 % delle azioni in circolazione).

Il dichiarante certifica l'assenza di informazioni negative non divulgate e firma la dichiarazione standard prevista dalla Regola 144. Non sono forniti altri dati operativi o finanziari.

Alphatec Holdings, Inc. (ATEC) – Aviso de Venta Propuesta según el Formulario 144

El insider Tyson Marshall planea vender hasta 18,092 acciones comunes a través de Morgan Stanley Smith Barney alrededor del 5 de agosto de 2025. Al precio declarado, el lote tiene un valor de $269,688.68. Con 147,983,775 acciones en circulación, la venta representa aproximadamente el 0.012 % del float de ATEC.

Las acciones provienen de la consolidación de acciones restringidas bajo un plan de compensación registrado. Marshall ya ha vendido 14,378 acciones en los últimos tres meses por $171,952, sumando disposiciones recientes y propuestas a 32,470 acciones (≈ 0.022 % de las acciones en circulación).

El declarante certifica que no posee información adversa no divulgada y firma la representación estándar requerida por la Regla 144. No se proporcionan otros datos operativos o financieros.

Alphatec Holdings, Inc. (ATEC) – Form 144 제안된 매각 통지

내부자 Tyson Marshall는 2025년 8월 5일경 Morgan Stanley Smith Barney를 통해 최대 18,092 보통주를 매각할 예정입니다. 신고 가격 기준으로 해당 주식의 가치는 $269,688.68입니다. 총 147,983,775주가 발행된 가운데, 이번 매각은 ATEC 유통 주식의 약 0.012 %에 해당합니다.

이 주식은 등록된 보상 계획에 따른 제한 주식 권리 확정에서 비롯된 것입니다. Marshall은 지난 3개월 동안 이미 14,378주$171,952에 매각했으며, 최근 및 제안된 매각 총량은 32,470주(전체 주식의 약 0.022 %)에 이릅니다.

신고자는 공개되지 않은 부정적 정보가 없음을 증명하며, 표준 Rule 144 진술서에 서명했습니다. 다른 운영 또는 재무 데이터는 제공되지 않았습니다.

Alphatec Holdings, Inc. (ATEC) – Avis de vente proposée au titre du formulaire 144

L'initié Tyson Marshall prévoit de vendre jusqu'à 18 092 actions ordinaires via Morgan Stanley Smith Barney aux alentours du 5 août 2025. Au prix déclaré, le lot vaut 269 688,68 $. Avec 147 983 775 actions en circulation, la vente représente environ 0,012 % du flottant d'ATEC.

Les actions proviennent d'un acquisition d'actions restreintes dans le cadre d'un plan de rémunération enregistré. Marshall a déjà vendu 14 378 actions au cours des trois derniers mois pour 171 952 $, portant le total des cessions récentes et proposées à 32 470 actions (≈ 0,022 % des actions en circulation).

Le déclarant certifie qu'il n'y a pas d'informations défavorables non divulguées et signe la déclaration standard prévue par la règle 144. Aucune autre donnée opérationnelle ou financière n'est fournie.

Alphatec Holdings, Inc. (ATEC) – Form 144 Mitteilung über geplanten Verkauf

Insider Tyson Marshall beabsichtigt, bis zu 18.092 Stammaktien über Morgan Stanley Smith Barney etwa am 5. August 2025 zu verkaufen. Zum Einreichungspreis hat das Paket einen Wert von 269.688,68 $. Bei 147.983.775 ausstehenden Aktien entspricht der Verkauf etwa 0,012 % des frei handelbaren Bestands von ATEC.

Die Aktien stammen aus der Vesting von eingeschränkten Aktien im Rahmen eines registrierten Vergütungsplans. Marshall hat in den letzten drei Monaten bereits 14.378 Aktien für 171.952 $ verkauft, womit sich die jüngsten und geplanten Verkäufe auf 32.470 Aktien (ca. 0,022 % des ausstehenden Aktienkapitals) summieren.

Der Anmelder bestätigt, dass keine nicht offengelegten negativen Informationen vorliegen, und unterzeichnet die Standarderklärung gemäß Regel 144. Weitere operative oder finanzielle Daten werden nicht bereitgestellt.

As filed with the Securities and Exchange Commission on August 5, 2025

Registration No. 333-

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

CERUS CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   68-0262011

(State or other jurisdiction of

Incorporation or organization)

 

(I.R.S. Employer

Identification No.)

1220 Concord Avenue, Suite 600

Concord, California 94520

(Address, including zip code, of principal executive offices)

Cerus Corporation Amended and Restated 2024 Equity Incentive

Plan

(Full title of the plan)

Chrystal N. Jensen

Chief Legal Officer, General Counsel and Secretary

Cerus Corporation

1220 Concord Avenue, Suite 600

Concord, California 94520

(925) 288-6000

(Name, address, and telephone number, including area code, of agent for service)

 

 

Copies to:

Chadwick L. Mills

Cooley LLP

3 Embarcadero Center, 20th Floor

San Francisco, California 94111-5800

(415) 693-2000

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 
 


EXPLANATORY NOTE

This registration statement on Form S-8 (the “Registration Statement”) is being filed for the purpose of registering an additional 10,000,000 shares of the Registrant’s Common Stock, $0.001 par value, to be issued pursuant to the Registrant’s Amended and Restated 2024 Equity Incentive Plan (the “EIP”). The shares of the Registrant’s Common Stock previously reserved for issuance under the EIP were registered on the Registrant’s Registration Statement on Form S-8 (File No. 333-281197) filed with the Securities and Exchange Commission (the “Commission”) on August  1, 2024.


PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

The documents containing the information specified in this Part I will be sent or given to participants as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the “Securities Act”). In accordance with the rules and regulations of the Securities and Exchange Commission (the “Commission” or “SEC”) and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

The following documents have been filed by the Registrant with the Commission and are incorporated herein by reference:

 

   

the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Commission on February 26, 2025 (the “2024 Form 10-K”);

 

   

the information specifically incorporated by reference into the 2024 Form 10-K from the Registrant’s definitive proxy statement on Schedule 14A, filed with the Commission on April 23, 2025;

 

   

the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, filed with the Commission on May 1, 2025;

 

   

the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025, filed with the Commission on August 5, 2025;

 

   

the Registrant’s Current Reports on Form 8-K, filed with the Commission on February  6, 2025, June  9, 2025 and June 23, 2025; and

 

   

the description of the Registrant’s Common Stock contained in Exhibit 4.2 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items, prior to the filing of a post-effective amendment to this Registration Statement which indicates that all of the shares of Common Stock offered have been sold or which deregisters all of such shares then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such documents.

For purposes of this Registration Statement, any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

Item 4. Description of Securities.

Not applicable.

Item 5. Interests of Named Experts and Counsel.

Not applicable.


Item 6. Indemnification of Directors and Officers.

As permitted by Delaware law, the Registrant’s amended and restated certificate of incorporation provides that no director will be personally liable to the Registrant or the Registrant’s stockholders for monetary damages for breach of fiduciary duty as a director, except for liability:

 

   

for any breach of the duty of loyalty to the Registrant or the Registrant’s stockholders;

 

   

for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law;

 

   

for unlawful payment of dividends or unlawful stock repurchases or redemptions under Section 174 of the Delaware General Corporation Law; and

 

   

for any transaction from which the director derived an improper personal benefit.

The Registrant’s amended and restated bylaws provide that:

 

   

the Registrant is required to indemnify the Registrant’s directors and executive officers to the fullest extent not prohibited by law, subject to limited exceptions;

 

   

the Registrant may indemnify the Registrant’s other officers, employees and agents as set forth in the Delaware General Corporation Law;

 

   

the Registrant is required, to the fullest extent not prohibited by law, to advance expenses to the Registrant’s directors and executive officers as incurred in connection with legal proceedings against them for which they may be indemnified, against an undertaking by the indemnified party to repay such advances if it is ultimately determined that the indemnified party is not entitled to indemnification; and

 

   

the rights conferred in the amended and restated bylaws are not exclusive.

The Company has entered into indemnification agreements with each of the Registrant’s directors and executive officers that require the Registrant to indemnify these individuals against expenses, witness fees, damages, judgments, fines and settlement amounts incurred by the director or officer in any action or proceeding, whether actual, pending or threatened, subject to certain limitations, to which any of these individuals may be made a party by reason of the fact that he or she is or was a director or an executive officer of the Registrant or is or was serving or at any time serves at the request of the Registrant as a director, officer, employee or other agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise.

Item 7. Exemption from Registration Claimed.

Not Applicable.

Item 8. Exhibits.

 

Exhibit
Number

    
 4.1(1)    Amended and Restated Certificate of Incorporation of Cerus Corporation.
 4.2(1)    Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cerus Corporation.
 4.3(4)    Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cerus Corporation.
 4.4(5)    Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Cerus Corporation.
 4.5(2)    Amended and Restated Bylaws of Cerus Corporation.
 4.6(3)    Specimen Stock Certificate.
 5.1    Opinion of Cooley LLP.
23.1    Consent of Independent Registered Public Accounting Firm.
23.2    Consent of Cooley LLP is contained in Exhibit 5.1 to this Registration Statement.
24.1    Power of Attorney is contained on the signature pages.
99.1(6)    Cerus Corporation Amended and Restated 2024 Equity Incentive Plan.
107    Filing Fee Table.

 

(1)

Incorporated by reference to the like-described exhibit to the Registrant’s Quarterly Report on Form 10-Q (File No. 000-21937), for the quarter ended September 30, 2012, filed with the Commission on November 8, 2012.

(2)

Incorporated by reference to the like-described exhibit to the Registrant’s Current Report on Form 8-K (File No. 000-21937), filed with the Commission on January 5, 2024.

(3)

Incorporated by reference to the like-described exhibit to the Registrant’s Quarterly Report on Form 10-Q (File No. 000-21937), for the quarter ended September 30, 2009, filed with the Commission on November 6, 2009.

(4)

Incorporated by reference to the like-described exhibit to the Registrant’s Quarterly Report on Form 10-Q (File No. 000-21937), for the quarter ended June 30, 2014, filed with the Commission on August 8, 2014.

(5)

Incorporated by reference to the like-described exhibit to the Registrant’s Quarterly Report on Form 10-Q (File No. 000-21937), for the quarter ended June 30, 2021, filed with the Commission on August 3, 2021.

(6)

Incorporated by reference to the like-described exhibit to the Registrant’s Quarterly Report on Form 10-Q (File No. 000-21937), for the quarter ended June 30, 2025, filed with the Commission on August 5, 2025.


Item 9. Undertakings.

1. The undersigned Registrant hereby undertakes:

(a) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended;

(ii) To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement.

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;

Provided, however, that paragraphs (a)(i) and (a)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference herein.

(b) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(c) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

2. The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

3. Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Concord, State of California, on this 5th day of August, 2025.

 

Cerus Corporation

 

By:  

/s/ William M. Greenman

  William M. Greenman
  President and Chief Executive Officer

POWER OF ATTORNEY

Each person whose signature appears below constitutes and appoints William M. Greenman and Kevin D. Green, each acting alone, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

  

Date

/s/ William M. Greenman

William M. Greenman

  

President, Chief Executive Officer and Chair of

the Board of Directors

(Principal Executive Officer)

   August 5, 2025

/s/ Kevin D. Green

   Chief Financial Officer    August 5, 2025
Kevin D. Green    (Principal Financial and Accounting Officer)   

/s/ Eric H. Bjerkholt

   Director    August 5, 2025
Eric H. Bjerkholt      

/s/ Dean Gregory

   Director    August 5, 2025
Dean Gregory      

/s/ Ann Lucena

   Director    August 5, 2025
Ann Lucena      

/s/ Timothy L. Moore

   Director    August 5, 2025
Timothy L. Moore      

/s/ Jami Nachtsheim

   Director    August 5, 2025
Jami Nachtsheim      

/s/ Hua Shan, M.D., Ph.D.

   Director    August 5, 2025
Hua Shan, M.D., Ph.D.      

/s/ Frank Witney, Ph.D.

   Director    August 5, 2025
Frank Witney, Ph.D.      

FAQ

How many ATEC shares are being sold under this Form 144?

18,092 common shares are listed for sale.

What is the estimated value of the proposed ATEC share sale?

The filing states an aggregate market value of $269,688.68.

When is the approximate sale date for the ATEC shares?

The notice lists 08/05/2025 as the expected sale date.

How many ATEC shares has the filer sold in the past three months?

Tyson Marshall sold 14,378 shares for $171,952 during the last three months.

What percentage of Alphatec's outstanding shares does the proposed sale represent?

Approximately 0.012 % of the 147,983,775 shares outstanding.

Which broker will execute the ATEC share sale?

The shares will be sold through Morgan Stanley Smith Barney LLC.
Cerus

NASDAQ:CERS

CERS Rankings

CERS Latest News

CERS Latest SEC Filings

CERS Stock Data

242.77M
182.17M
3.35%
74.75%
3.86%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
CONCORD